May 3 |
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q1 2024 Earnings Call Transcript
|
May 3 |
PROCEPT BioRobotics First Quarter 2024 Earnings: Beats Expectations
|
May 1 |
Procept GAAP EPS of -$0.51 beats by $0.04, revenue of $44.5M beats by $2.83M
|
May 1 |
Procept GAAP EPS of -$0.51, revenue of $44.5M
|
May 1 |
PROCEPT BioRobotics Corporation (PRCT) Q1 2024 Earnings Call Transcript
|
May 1 |
Biotech Leader Procept BioRobotics Jumps Past Buy Point On Earnings
|
May 1 |
PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue Estimates
|
May 1 |
PROCEPT BioRobotics Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
|
Apr 29 |
Procept Q1 2024 Earnings Preview
|
Apr 29 |
Late Breaking Abstract Presented at the Japanese Urological Association Annual Meeting on Aquablation Therapy Outcomes for Men in Japan with Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia
|